To me, it looks like Renaissance Tech selling out. They have been known to eliminate a position in a big way when the numbers dictate. It hasn't taken the stock down but the sell down is the most likely reason SVA didn't participate in the biotech bubble. The price has recently been capped at $5.05. Hopefully as soon as this is cleaned up, with some favorable earnings, punctuated by some good news on pipeline drugs SVA can reach new 52 week highs.
Seeking Alpha has earnings being released "before the open" Monday. It was on the CNBC site under Seeking Alpha's "Next Week in Biotech." Guess we'll find out the easy or hard way if earnings are out today within the hour.
Eli Lilly & Co. agreed to form one of the broadest collaborations to date between a large Western drug maker and a Chinese biotechnology company, Innovent Biologics?
And when is SVA actually releasing earnings? This afternoon? Thanks.
Fingers and toes crossed for great earnings and favorable news releases. With this company and their lack of information disclosure, crossing digits is my investment strategy. I still believe that Asian science is as good if not better than Western, until it isn't. Best of luck. to all longs.
Hope you're right. I've got a 5,000 share bet that the Chinese DO give a darn about having their own vaccination provider instead of relying on other non Asian sources. BUT given the lack of information released by SVA on vaccine progress it seems like SVA isn't remotely trying. There isn't any company news for anything. What is that?
Unfortunately for us SVA holders Chinese leaders view a pandemic as population control. Therefore there isn't any announcement of more funds being being directed to creating a vaccine. When the pandemic comes they'll just buy vaccines from non Chinese pharma's Sanofi, PFE, GSK and MRK, if there is any left after those companies vaccinate their own populations.
Buyer and seller going back and forth. A favorable news release or surprisingly good earnings might make a difference to the upside. The recent headline about bird flu mutations/pandemic possibilities didn't register. A It's apparent that increasing the share price with any PR is not on their agenda. Best of luck to all longs. Think we're going to need all the luck we can get with this crew.
Not complaining. Well maybe a little bit. Bought 3,000 yesterday at $5.05 and watched the stock fall off the table from the git go this morning. Bought 2,000 more at 4.65 and toyed with the idea of buying the 5000 offer at 4.65 after my purchase. Then BANG!! It catches a bid and the stock makes a full U turn. Hope it augurs well for the near future for all of us. SVA is due for a surge. Too much talent not to produce something of value.
Sorry guys but I bought SVA yesterday which means it has to correct today. Good luck to all longs.